Otsuka saw the highest growth of 129% in patent filings in December and 116% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 94% and grants by 116%. GlobalData’s DataBook provides a comprehensive analysis of Otsuka‘s patent filings and grants. Buy the databook here.
Otsuka has been focused on protecting inventions in United States(US) with four publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 43% filings and 20% grants. The United States(US), South Korea(KR), Denmark(DK), and European Patent Office(EPO) patent Office are among the top ten patent offices where Otsuka is filings its patents. Among the top granted patent authorities, Otsuka has 20% of its grants in United States(US) and 20% in Finland(FI).
Patents related to rare diseases and health & wellness lead Otsuka's portfolio
Otsuka has the highest number of patents in rare diseases followed by, health & wellness and healthtech. For rare diseases, nearly 22% of patents were filed and 9% of patents were granted in Q4 2023.
Petrochemicals related patents lead Otsuka portfolio followed by automotive materials, and food
Otsuka has highest number of patents in petrochemicals followed by automotive materials, food, healthcare it, and tires and wheels. For petrochemicals, nearly 6% of patents were filed and 5% of patents were granted in Q4 2023.
For comprehensive analysis of Otsuka's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.